Monitor for signs of financial distress as this aggressive financing structure suggests urgent capital needs. Watch for future dilution as notes convert at significant discounts to market. The 15% mandatory prepayment from future financings could limit the company's ability to raise additional capital on favorable terms.
Price Chart
Executive Summary
Tenon Medical raised $4.3 million through a private placement of senior convertible promissory notes with a 20% original issue discount. The notes are convertible into common stock at 80% of the VWAP over three trading days prior to conversion, subject to a floor price, and mature in September 2026. The company must prepay 15% of the note balance from proceeds of any future financing. This represents a dilutive capital raise under aggressive terms, indicating urgent funding needs.
Key Financial Metrics
Key Facts
- Tenon Medical raised $4.3 million through senior convertible promissory notes with a 20% original issue discount
- Notes are convertible into common stock at 80% of the VWAP over three trading days prior to conversion, creating significant dilution
- The company must prepay 15% of the note balance from proceeds of any future financing
- The notes mature in September 2026 and can be extended by the company with a 5% principal increase
- The company engaged WallachBeth Capital as placement agent, paying 7% cash fee plus $65,000 in expenses
Financial Impact
The $4.3 million raise provides immediate liquidity but at highly dilutive terms with a 20% OID and conversion at 80% of market price. The 15% mandatory prepayment from future financings constrains future capital options.
Risk Factors
- Significant shareholder dilution as notes convert at 80% of market price
- Financial constraint from mandatory 15% prepayment from future financing proceeds
- Potential for further dilutive financing if the company cannot meet obligations by maturity
- High cost of capital with 20% original issue discount and potential 5% extension fee
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-028569 |
| Document: ea028193701ex4-1.htm | 0001213900-26-028569 |
| Document: ea0281937-8k_tenon.htm | 0001213900-26-028569 |
| Document: ea028193701ex99-1.htm | 0001213900-26-028569 |
| Document: 0001213900-26-028569-index-headers.html | 0001213900-26-028569 |
| Document: 0001213900-26-028569-index.html | 0001213900-26-028569 |
| Document: 0001213900-26-028569.txt | 0001213900-26-028569 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $2.20 | awaiting T+20 | — | $2.20 (+0.23%) |
Oct 16, 2026 10d ago | 424B5 | $2.45 | awaiting T+20 | — | $2.20 (+10.00%) |
Oct 13, 2026 14d ago | EFFECT | $2.89 | awaiting T+20 | — | $2.20 (+23.70%) |
Oct 9, 2026 17d ago | 3 | $2.98 | awaiting T+20 | — | $2.20 (−26.01%) |
Sep 16, 2026 5w ago | 8-K | $4.20 $2.91 | ▲ +30.71% | ▲ +31.92% | $2.20 (+47.50%) |
Sep 11, 2026 6w ago | Insider Buy | $5.93 $3.41 | ▼ −42.50% | ▼ −44.36% | $2.20 (−62.82%) |
Sep 9, 2026 6w ago | 8-K | $2.44 $3.50 | ▲ +43.44% | ▲ +41.50% | $2.20 (−9.63%) |
Sep 1, 2026 7w ago | Insider Buy | $4.47 $4.04 | ▲ +9.62% | ▲ +9.71% | $2.20 (+50.67%) |
Aug 31, 2026 8w ago | 8-K | $4.53 $2.73 | ▲ +39.74% | ▲ +39.55% | $2.20 (+51.32%) |
Aug 31, 2026 8w ago | 3 | $4.53 $2.73 | ▼ −39.74% | ▼ −39.55% | $2.20 (−51.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers